This presentation from Wendy Hendrie looks at how health professionals can help people with MS cope with ataxia. It was presented at the MS Trust Annual Conference in November 2013.
Ataxia Physiotherapy Presentation - COAP study dayAtaxia UK
This is a presentation given by Anita Watson, Lecturer in Physiotherapy, at the Care of Ataxia Patients (COAP) study day on 18 November 2011 in Manchester. It is an overview of physiotherapy treatment options for people with ataxia.
Stroke rehabilitation and its aspects to work with patients with hemiplegia and other effects of stroke, other than that you will see some pictures of the used interventions and adaptive equipment used with stroke patients
Ataxia Physiotherapy Presentation - COAP study dayAtaxia UK
This is a presentation given by Anita Watson, Lecturer in Physiotherapy, at the Care of Ataxia Patients (COAP) study day on 18 November 2011 in Manchester. It is an overview of physiotherapy treatment options for people with ataxia.
Stroke rehabilitation and its aspects to work with patients with hemiplegia and other effects of stroke, other than that you will see some pictures of the used interventions and adaptive equipment used with stroke patients
Prezentace určená převážně medikům na téma pes equinovarus congenitus, pes calcaneovalgus, talus verticalis, metatarsus varus congenitus, pes planovalgus, hallux valgus, hallux rigidus, pes transversoplanus, deformity prstů nohy, aseptické kostní nekrózy nohy, bolesti paty, syndrom diabetické nohy.
Multiple sclerosis a devastating progressive condition cased due to demyelination and gliotic changes in CNS. Physiotherapy managemnet options available for most of the clinical features are enumerated
Multiple Sclerosis (MS) is a chronic, usually progressive, disease that primarily affects young adults. More than 350,000 people in the United States and 2.5 million worldwide have been diagnosed with MS. Multiple Sclerosis Physical Therapy for Multiple Sclerosis is a disease that involves the loss of myelin, a material that covers and protects the nerves in the body's central nervous system.
Prezentace určená převážně medikům na téma pes equinovarus congenitus, pes calcaneovalgus, talus verticalis, metatarsus varus congenitus, pes planovalgus, hallux valgus, hallux rigidus, pes transversoplanus, deformity prstů nohy, aseptické kostní nekrózy nohy, bolesti paty, syndrom diabetické nohy.
Multiple sclerosis a devastating progressive condition cased due to demyelination and gliotic changes in CNS. Physiotherapy managemnet options available for most of the clinical features are enumerated
Multiple Sclerosis (MS) is a chronic, usually progressive, disease that primarily affects young adults. More than 350,000 people in the United States and 2.5 million worldwide have been diagnosed with MS. Multiple Sclerosis Physical Therapy for Multiple Sclerosis is a disease that involves the loss of myelin, a material that covers and protects the nerves in the body's central nervous system.
BALANCE
BALANCE SYSTEM
TYPES OF BALANCE
MECHANISM
CORRELATION
BALANCE TRAINING
MANAGEMENT
STRATEGIES
PHYSIOTHERAPY INTERVENTION
BALANCE TRAINING IN ELDERLY
OUTCOME MEASURES
Detailed explanation about balance and balance training.
Balance refers to an individuals ability to maintain their line of gravity within their Base of support (BOS). It can also be described as the ability to maintain equilibrium, where equilibrium can be defined as any condition in which all acting forces are cancelled by each other resulting in a stable balanced system.
BALANCE SYSTEMS:
The following systems provides input regarding the body's equilibrium and thus maintains balance.
Somatosensory / Proprioceptive System
Vestibular System
Visual System
The Central Nervous System receives feedback about the body orientation from these three main sensory systems and integrates this sensory feedback and subsequently generates a corrective, stabilizing torque by selectively activating muscles. In normal condition, healthy subjects rely 70% on somatosensory information and 20% Vestibular & 10% on Vision on firm surface but change to 60% vestibular information, 30% Vision & 10% somatosensory on unstable surface.
SOMATOSENSORY SYSTEM:
Proprioceptive information from spino-cerebellar pathways, processed unconsciously in the cerebellum, are required to control postural balance. Proprioceptive information has the shortest time delays, with monosynaptic pathways that can process information as quickly as 40–50 ms and hence the major contributor for postural control in normal conditions.
VESTIBULAR SYSTEM:
The vestibular system generates compensatory responses to head motion via:
Postural responses (Vestibulo-Spinal Reflex) - keep the body upright and prevent falls when the body is unexpectedly knocked off balance.
Ocular-motor responses (Vestibulo-Ocular Reflex) - allows the eyes to remain steadily focused while the head is in motion.
Visceral responses (Vestibulo-Colic Reflex) - help keep the head and neck centred, steady, and upright on the shoulders.
VISUAL SYSTEM:
For non-impaired individuals, under normal conditions the contribution of visual system to postural control is partially redundant as the visual information has longer time delays as long as 150-200 ms.
Friedrich et al. observed that adults with visual disorders were able to adapt peripheral, vestibular, somatosensory perception and cerebellar processing to compensate for their visual information deficit and to provide good postural control.
In addition, Peterka found that adults with bilateral vestibular deficits can enhance their visual and proprioceptive information even more than healthy adults in order to reach effective postural stability.
The influence of moving visual fields on postural stability depends on the characteristics of the visual environment, and of the support surface, including the size of the base of support, its rigidity or compliance.
TYPES OF BALANCE:
Balance can be classified in to :
Static Balance:
Dynamic Balance
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
1. Helping people with MS
cope with ataxia
Wendy Hendrie PhD MSc MCSP
Specialist Physiotherapist in MS
Norwich MS Centre
2. Two main approaches
• Rehabilitation
• Compensatory
Mobility
Upper limb
Posture
3. Many systems responsible for movement quality
SENSORY
CEREBELLAR
VESTIBULAR
MOVEMENT
QUALITY
MOTOR
VISUAL
Deficits in one or more systems
ataxic symptoms
5. Rehabilitation
• Some studies of rehab interventions have
shown improvements in gait, trunk control
and activities.
• Motor relearning may be possible in damaged
cerebellum?
• Very few studies in MS.
6. Rehabilitation
• Interventions
– Dynamic task practice
– Challenges to limits of stability
– Strengthening
– Flexibility
– PNF
– Treadmill training (not MS) + over-ground
training
7. No evidence in ataxia but may be useful…
•
•
•
•
•
Yoga
T’ai Chi
Pilates
Horse riding
Hydrotherapy
8. Managing ataxia
Treatment of ataxic patients requires balance
between facilitation of improved control and
the recognition and acceptance of necessary
compensation which is essential for function.
Jon Marsden
10. Balance and Mobility Aids
• No studies have evaluated role of aids
• Case-by-case basis
• Rollators
11. Tendency to ‘fix’
posture (especially
if vestibular
problems).
May be dangerous
as lateral sidesteps to aid
balance is
impeded.
12. Balance and Mobility Aids
• Walking / trekking / Nordic poles – light tough
contact, more weight through lower limbs
• Difficult placing sticks / poles if person has
dysmetria or tremor
• Can weight all hollow mobility aids with sand /
ball-bearings
13. More strategies to improve mobility
• Visually guided stepping
- eyes and locomotor system work together during
walking
- rehearsal of intended placement of steps before
walking
- task-specific and short-lived
- ‘mindfullness’ of movement
14. Wobble cushion in
preparation for
walking cerebellar ataxia –
slow to start, slow
to stop – delay in
agonist/antagonist
initiation.
15. Axial weighting – vest or belt
• Use weights to increase
sensation through joints.
Increases feelings of
steadiness.
• To counteract forward or
backward lean.
• Reaching activities in
sitting.
20. Strategies for the upper limb
• Manipulation of visual information
- tremor and dysmetria may improve if
movement not visually guided
- can work well in people with intention
tremor
- find the ‘quiet arc’ of movement
23. Cooling
• 15 minutes of cooling
• use wine cooler over
forearm
• decrease in tremor
can last for up to 30
minutes (eating, ISC)
24. Wrist weighting
• Grade weight until
tremor diminished
enough for function
• Beware of making
tremor, instability,
weakness, fatigue or
rebound worse
• Up to 4lbs
39. Postural case study
•
•
•
•
•
•
•
49 year old lady with MS
Gross ataxia of trunk, head and upper limbs
Living at home
Refusing help with eating
Weight loss
Chest infection
Admitted to hospital
40.
41.
42. Just to make things difficult…..
• Mixed causes
• Reduced joint range
• Weakness
• Emotional impact
• Spasticity
• Cognitive problems
• Eye problems
• Weight loss
• Anxiety/fear
• Social stigma
43. In summary
• Deconditioning makes everything worse so
encourage activity!
• May need to use a variety of compensatory
interventions
• Check medication (especially anti-spasticity)
as muscle weakness may be contributing to
ataxia